Director’s Interest
180626_Director's Interest
Top 20 Shareholders June 2018
Top 20 04.06.18
Epichem Award
180607_Epichem Award
Reformulation Update
180528 Reformulation Update
Chief Executive Officer resigns
6A884712_PAA
PharmAust Appendix 4C and Shareholders Update (Q3, 2018 FY)
180501_4C and Shareholders Update_March
Top 20 Shareholders April 2018
Top 20 Share Holders April 2018
PharmAust enters option to license agreement with Elanco for dog cancer treatment
180418_Elanco PharmAust Agreement
Trading Halt
180416_Trading Halt
Wayne Best appointed Epichem Chairman and Dr Keenan as CEO
180410_Epichem New CEO_final